-+ 0.00%
-+ 0.00%
-+ 0.00%

CELLDEX INITIATES GLOBAL REGISTRATIONAL PHASE 3 PROGRAM OF BARZOLVOLIMAB IN COLD URTICARIA AND SYMPTOMATIC DERMOGRAPHISM

路透·12/09/2025 13:01:48

登录查看新闻详情